Men who want lower estrogen levels to, decrease prostate cancer risks or with prostate cancer therapy. (yourhormones.com)
«Gene defect as a potential gateway for targeted prostate cancer therapy.» (sciencedaily.com)
The researchers, at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, say their test is the first developed for a precision prostate cancer therapy targeted at specific genetic faults within tumours. (sciencedaily.com)